Solid Biosciences, Inc. (SLDB)
6.41
-0.52
(-7.50%)
USD |
NASDAQ |
Feb 11, 15:58
Solid Biosciences Total Assets (Quarterly) : 273.91M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 2.252B |
| Sarepta Therapeutics, Inc. | 3.493B |
| Plus Therapeutics, Inc. | 18.67M |
| BioStem Technologies, Inc. | 62.39M |
| Iovance Biotherapeutics, Inc. | 904.95M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 55.97M |
| Shareholders Equity (Quarterly) | 217.95M |
| Debt to Equity Ratio | 0.1007 |
| Current Ratio | 6.737 |
| Net Debt Paydown Yield | 0.14% |